Investor / VC

Aspen Pharmacare has completed the €197m sale of Ovestin's European rights to privately owned Ennogen Healthcare International. Aspen received the payment on 3 November after Ennogen secured unconditional funding for the acquisition. Ennogen will also pay €4m for existing stocks of the product. Aspen will retain a manufacturing and supply role under a separate 10-year [...]

Women's health pharmaceutical company Theramex is set to be acquired in a deal reportedly worth €2.6bn, with completion expected in the first half of 2027. The London-headquartered business provides treatments for menopause, osteoporosis, contraception, uterine health and fertility. The transaction remains subject to regulatory approval. Financial terms have not been formally disclosed. Theramex operates in [...]

The Victorian government has committed a further A$10m to the Alice Anderson Fund, doubling its initial 2021 investment in women-founded startups. The funding will provide capital, business networks and support to help more women entrepreneurs grow their companies. The fund aims to address the gender gap in Australian venture capital, where female founders receive a [...]

TFP Fertility Group has acquired Manchester Fertility Group, expanding its UK operations and presence in northwest England. Financial terms were not disclosed. TFP operates fertility and reproductive health clinics in the UK and Poland and has more than 35 years of clinical heritage. Manchester Fertility Group has provided fertility services since 1986 and operates a [...]

Allara has raised US$30m to develop AI tools, expand access to women’s healthcare and fund research, bringing its total funding to US$75m. The US virtual healthcare company provides integrated care for hormonal, metabolic and reproductive conditions. In a survey of more than 1,600 women joining Allara, 58 per cent had already consulted at least two [...]

Women’s health medical device company Ark Surgical has secured further institutional backing from JNF and the Israel Innovation Authority (IIA) as it accelerates the US commercial expansion of its surgical tissue containment technology. Both organisations have previously backed Ark, making the renewed support a significant vote of confidence in the company’s technology, leadership team and [...]

Cambridge health tech company TidalSense has secured £14.2m in funding led by Cross-Border Impact Ventures to expand its AI-powered lung disease test across the NHS and into Europe and the US. The investment, which also includes returning backers BGF, Airstream Capital and Foresight Group, will fund the rollout of a handheld diagnostic device that can [...]

Women’s health startup Ovum has raised US$4m in seed funding to develop its AI health journal and expand research using women’s health data. The round valued the Melbourne startup at US$18m. Ovum plans to use the funding to develop its artificial intelligence technology and longitudinal datasets, which track health information over time to reveal changes [...]

Australian startup Proseek Bio has raised AU$1.5m in an oversubscribed seed round to commercialise its ovarian cancer blood test. With up to 80 per cent of surgeries for suspected ovarian cancer coming back benign, the company says better diagnostics are urgently needed. Proseek Bio says its test is designed to support earlier and more precise [...]

Wysa has secured £5.3m to adapt a digital mental health programme for adolescent girls in rural India. The funding comes from Wellcome and will support a scale-up study to tailor a clinically validated digital intervention for girls facing limited autonomy, restricted access to technology, lower literacy, stigma and family gatekeeping. Digital interventions are app-based programmes [...]